4Lind,K,Benzon MW,Jensen JS,et al.A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946–1995[J].Eur J Epidemiol,1997,13(5):581-586.
5Hauksdóttir GS,Jónsson T,Sigurdardóttir V,et al.Seroepidemiology of Mycoplasma pneumoniae Infections in Iceland 1987–96[J].Scand J Infect Dis,1998,30(2):177-180.
6Ito I,Ishida T,Osawa M,et al.Culturally verified Mycoplasma pneumoniae in Japan:a long-term observation from 1979-99[J].Epidemiol Infect,2001,127(2):365-367.
7Su CJ,Chavoya A,Dallo SF,et al.Sequence divergency of the cytadhesin gene of Mycoplasma pneumoniae[J].Infect Immun,1990,58(8):2669-2674.
8Cousin-Allery A,Charron A,de Barbeyrac B,et al.Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis.Application to French and Danish isolates[J].Epidemiol Infect,2000,124(1):103-111.
9Dumke R,Catrein I,Pirkl E,et al.Subtyping of Mycoplasma pneumoniae isolates based on extended genome sequencing and on expression profiles[J].Int Med Microbiol,2003,292 (7-8):513-525.
10Sasaki T,Kenri T,Okazaki N,et al.Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene[J].J Clin Microbiol,1996,34(2):447-449.
二级参考文献34
1Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
2Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
3Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
5Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
6Lim WS, Macfarlane JT, Boswell TC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospilah implications for management guidelines [J]. Thorax, 2001, 56(4): 296-301.
7Ngeow YF, Suwanjutha S, Chantarojanasriri T, et al. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia[J]. Int J Infect Dis, 2005, 9(3): 144-153.
8Shi Y, Xia X, Song Y, et al. Assessment of polymerase chain reaction and serology for detection of Chlamydia pneumoniae in patients with acute respiratory tract infection[J]. Chin MedJ, 2002, 115(2): 184-187.
9Gaydos CA, Quinn TC, Eiden JJ. Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene [J]. J Cln Mcrobol, 1992,30(4): 796- 800.
10Mauch H. Diagnosis of acute respiratory tract infections: serology and new methods[J]. Clin Microbiol Inject, 5996, 1 Suppl 2: S16-S19.
